| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,596,100 | 3,507,900 | 3,423,100 | 3,583,604 | | Cost of Revenue | 4,220,200 | 3,134,200 | 3,041,300 | 3,217,894 | | | Gross Profit | 375,900 | 373,700 | 381,800 | 365,710 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,900 | 27,800 | 23,000 | 23,649 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 360,300 | 345,900 | 358,800 | 342,061 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 200 | 700 | 6,498 | | Earnings Before Interest And Taxes | 364,500 | 328,500 | 372,900 | 359,626 | | Interest Expense | 128,000 | 126,200 | 120,400 | 110,274 | | Income Before Tax | 236,500 | 202,300 | 252,500 | 249,352 | | Income Tax Expense | 6,600 | 2,200 | 15,200 | 9,208 | | Minority Interest | (42,500) |
-
|
-
| (12,083) | | | | Net Income From Continuing Ops | 205,700 | 200,100 | 237,300 | 228,061 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 187,400 | 200,100 | 237,300 | 228,061 | | Preferred Stock And Other Adjustments | 25,500 | (13,500) | (12,000) | (142,474) | | | Net Income Applicable To Common Shares | $212,900 | $186,600 | $225,300 | $85,587 |
|
0.51% Nasdaq 
Income Statement
